HIGHLIGHTS
- who: Constant Gillot and collaborators from the Department of Pharmacy, Research Institute for Life Sciences, Thrombosis and Hemostasis Center, University of, have published the article: Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome, in the Journal: Vaccines 2022, 10, 2056. of 14/07/2021
SUMMARY
The use of adenoviruses to develop vaccination strategies has been known for almost 20 years. The use of these viral_vectors is ideal for vaccine therapy due to their ability to induce innate immunity and adaptive immunity in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.